Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Latest Information Update: 11 Sep 2019
At a glance
- Drugs Temozolomide (Primary) ; Ropidoxuridine
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 07 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 24 Oct 2012 New trial record